Olav Bergheim

Olav is the Founder and Managing Director of Fjord Ventures LLC, a life sciences accelerator company whose portfolio includes Adagio Medical, Inc.; Allegro Medical, Inc.; Anaxiom Corporation; Kato Pharmaceuticals, Inc.; Metronom Health, Inc.; Prelude Corporation; Sonendo, Inc.; Volante Diagnostics, Inc.; and YAP Therapeutics, Inc. Each of these companies was founded by Olav. Previously, Olav was General Partner of Domain Associates, where he started VenPro; 3F Therapeutics (acquired by Medtronic); Vessix Vascular (acquired by Boston Scientific); Volcano Therapeutics (acquired by Phillips); and Glaukos Corporation. Earlier, Olav spent 18 years in general management positions at Baxter Healthcare Corporations.